HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[DRESS syndrome induced by anti-TB drugs].

AbstractOBJETIVE:
To describe the phenotype of DRESS syndrome induced by antituberculosis drugs.
METHODS:
Descriptive study, withdrawn from the review of the records of patients with DRESS syndrome, identified in the interconsultation of the Department of Research in Immunogenetics and Allergy, of the Insti-tuto Nacional de Enfermedades Respiratorias (INER) Ismael Cosío Villegas, among 2014 and 2020. Frequency analysis was performed. The associations between biomarkers and latency are calculated with the χ2 test and log-rank, and the evaluation of the change in the biomarkers with the Wilcoxon test. The value of p < 0.05 is considered statistically significant. For data analysis, the SPSS v.21 program was obtained.
RESULTS:
15 patients were identified; represented by 0.02% of total cases treated in the Department for so-meimmuno-allergic condition (15/7052); the main symptomatology were: rash (100%), eosinophilia (93%), fe-ver (80%), adenomegaly (60%), kidney damage (40%), liver damage (33%), and latency of 21 days. Liver damage was associated with prolonged latency (p = 0.02). After treatment, the total levels of eosinophils (p < 0.001) and liver and kidney biomarkers (p < 0.04) decreased. DRESS syndrome induced by antituberculosis drugs is not associated with the number of drugs prescribed or with the pattern of resistance of Mycobacterium tuberculosis.
CONCLUSIONS:
DRESS syndrome induced by antituberculosis drugs is an atypical clinical reaction, similar to other types of DRESS syndrome that respond favorably to systemic corticosteroids.
AuthorsGandhi Fernando Pavón-Romero, María Itzel Parra-Vargas, Rodrigo Rosas-Fernández, Fernando Ramírez-Jiménez, Katia Vanessa Gutiérrez-Quiroz, Luis Manuel Terán
JournalRevista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) (Rev Alerg Mex) Vol. 70 Issue 2 Pg. 55-63 (Jun 28 2023) ISSN: 2448-9190 [Electronic] Mexico
Vernacular TitleSíndrome de DRESS inducido por fármacos antituberculosos.
PMID37566768 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Adrenal Cortex Hormones
  • Antitubercular Agents
Topics
  • Humans
  • Adrenal Cortex Hormones (therapeutic use)
  • Antitubercular Agents (adverse effects)
  • Drug Hypersensitivity Syndrome (etiology)
  • Eosinophilia (chemically induced)
  • Eosinophils

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: